Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
    Most visited pages

        GETINGE MEDICAL TECHNOLOGY RDI (RSFF)

        Signature(s)

        Amount
        € 53,501,899.64
        Countries
        Sector(s)
        Sweden : € 53,501,899.64
        Industry : € 53,501,899.64
        Signature date(s)
        19/06/2008 : € 53,501,899.64

        Summary sheet

        Release date
        7 September 2007
        Status
        Reference
        Signed | 19/06/2008
        20060542
        Project name
        Promoter - financial intermediary
        Getinge Medical Technology RDI

        Getinge AB

        Proposed EIB finance (Approximate amount)
        Total cost (Approximate amount)
        Loan up to SEK 500 million. (EUR 54 million)
        Approximately SEK 1 billion. (EUR 109 million)
        Location
        Sector(s)
        Description
        Objectives

        The project concerns the part-financing of Getinge Group’s annual R&D expenditures in the 2007-2010 period.

        The project aims at maintaining and further developing Getinge’s leading position in the fields of medical care and technology.

        Environmental aspects
        Procurement

        The execution of the RDI programme will have no material environmental impact. All national and EU environmental legislation will be respected.

        The promoter is a private company and therefore not bound by EC Directives on procurement.

        Comments

        Article 267, point (c)

        Disclaimer

        Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
        They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

        General enquiries and comments

        The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
        Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
        Alternatively, the EIB can be contacted through its external offices.
        Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

        Media enquiries

        Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

        Complaints mechanism

        Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

        Zero tolerance against fraud and corruption

        The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

        Related publications